1-hexadecyl-2-acetyl-glycero-3-phosphocholine and prostaglandin e3

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with prostaglandin e3 in 1 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (prostaglandin e3)	Trials (prostaglandin e3)	Recent Studies (post-2010) (prostaglandin e3)
9,156	187	552	80	5	24

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fox, SC; Glenn, JR; Heptinstall, S; Iyú, D; Johnson, A; White, AE	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and prostaglandin e3

Article	Year
The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. Thrombosis and haemostasis, 2012, Volume: 107, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Atherosclerosis; Blood Platelets; Cardiovascular System; Dose-Response Relationship, Drug; Humans; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Receptors, Prostaglandin E	2012

Article

Year

The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function.

Thrombosis and haemostasis, 2012, Volume: 107, Issue:4

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Atherosclerosis; Blood Platelets; Cardiovascular System; Dose-Response Relationship, Drug; Humans; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Receptors, Prostaglandin E

2012